ENDOTOXIN AND HYPOXIA-INDUCED INTESTINAL NECROSIS IN RATS - THE ROLE OF PLATELET-ACTIVATING-FACTOR

被引:63
作者
CAPLAN, MS [1 ]
KELLY, A [1 ]
HSUEH, W [1 ]
机构
[1] NORTHWESTERN UNIV,CHILDRENS MEM HOSP,SCH MED,DEPT PATHOL,CHICAGO,IL 60614
关键词
D O I
10.1203/00006450-199205000-00002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We have previously shown that intravascular platelet activating factor (PAF) causes ischemic bowel necrosis in rats morphologically similar to neonatal necrotizing enterocolitis (NEC). Because endotoxin (LPS) and hypoxia are risk factors for NEC, we studied their effect on PAF metabolism and the development of intestinal injury. Young male Sprague-Dawley rats were anesthetized with pentobarbital and divided into six experimental groups: 1) control, 2) LPS alone (2 mg/kg), 3) hypoxia alone (5% O2), 4) LPS + hypoxia, 5) WEB 2086 (PAF antagonist) + LPS + hypoxia, and 6) SRI 63-441 (PAF antagonist) + LPS + hypoxia. Evaluations included blood pressure recording, superior mesenteric artery blood flow, arterial blood gas, white blood cell count, hematocrit, plasma PAF, plasma acetylhydrolase, plasma tumor necrosis factor, intestinal perfusion, and intestinal injury at 3 h. We found that LPS + hypoxia synergistically contributed to hypotension (mean blood pressure 27 +/- 5.6% baseline versus 101 +/- 3.9% control), metabolic acidosis (pH 7.05, base deficit 24 mEq/L), hemoconcentration, decreased superior mesenteric artery blood flow (2.2 +/- 0.3 mL/min versus 5.8 +/- 0.2 mL/min control), and intestinal injury. The morbidities resulting from LPS + hypoxia were partially or completely prevented by PAF antagonists. In addition, animals treated with LPS + hypoxia had neutropenia, elevated plasma acetylhydrolase, and elevated plasma TNF. These results suggest that endogenous PAF may contribute to LPS + hypoxia-induced intestinal hypoperfusion and necrosis.
引用
收藏
页码:428 / 434
页数:7
相关论文
共 34 条
  • [1] BARLOW B, 1974, J PEDIATR SURG, V9, P587, DOI 10.1016/0022-3468(74)90093-1
  • [2] IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR ISOLATION OF PLATELET-ACTIVATING FACTOR FROM OTHER PHOSPHOLIPIDS
    BLANK, ML
    SNYDER, F
    [J]. JOURNAL OF CHROMATOGRAPHY, 1983, 273 (02): : 415 - 420
  • [3] EFFECT OF PLATELET-ACTIVATING FACTOR ON MONOCYTE ACTIVATION AND PRODUCTION OF TUMOR NECROSIS FACTOR
    BONAVIDA, B
    MENCIAHUERTA, JM
    BRAQUET, P
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1989, 88 (1-2): : 157 - 160
  • [4] TUMOR NECROSIS FACTOR/CACHECTIN STIMULATES PERITONEAL-MACROPHAGES, POLYMORPHONUCLEAR NEUTROPHILS, AND VASCULAR ENDOTHELIAL-CELLS TO SYNTHESIZE AND RELEASE PLATELET-ACTIVATING-FACTOR
    CAMUSSI, G
    BUSSOLINO, F
    SALVIDIO, G
    BAGLIONI, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) : 1390 - 1404
  • [5] SERUM PAF ACETYLHYDROLASE INCREASES DURING NEONATAL MATURATION
    CAPLAN, M
    HSUEH, W
    KELLY, A
    DONOVAN, M
    [J]. PROSTAGLANDINS, 1990, 39 (06): : 705 - 714
  • [6] HYPOXIA CAUSES ISCHEMIC BOWEL NECROSIS IN RATS - THE ROLE OF PLATELET-ACTIVATING FACTOR (PAF-ACETHER)
    CAPLAN, MS
    SUN, XM
    HSUEH, W
    [J]. GASTROENTEROLOGY, 1990, 99 (04) : 979 - 986
  • [7] ROLE OF PLATELET ACTIVATING FACTOR AND TUMOR NECROSIS FACTOR-ALPHA IN NEONATAL NECROTIZING ENTEROCOLITIS
    CAPLAN, MS
    SUN, XM
    HSUEH, W
    HAGEMAN, JR
    [J]. JOURNAL OF PEDIATRICS, 1990, 116 (06) : 960 - 964
  • [8] CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974
  • [9] PLATELET-ACTIVATING-FACTOR MEDIATES HEMODYNAMIC-CHANGES AND LUNG INJURY IN ENDOTOXIN-TREATED RATS
    CHANG, SW
    FEDDERSEN, CO
    HENSON, PM
    VOELKEL, NF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (05) : 1498 - 1509
  • [10] ROLE OF OXYGEN DERIVED FREE-RADICALS IN PLATELET ACTIVATING FACTOR INDUCED BOWEL NECROSIS
    CUEVA, JP
    HSUEH, W
    [J]. GUT, 1988, 29 (09) : 1207 - 1212